Filter
863
Filtered Results: 863
Text search:
National
Formulary
Featured
Recommendations
99
New Publications
190
Language
Document type
No document type
376
Guidelines
250
Studies & Reports
104
Manuals
59
Strategic & Response Plan
45
Training Material
13
Situation Updates
7
Fact sheets
4
Brochures
2
Resource Platforms
2
Online Courses
1
Countries / Regions
Latin America and the Carribbean
70
Paraguay
47
Argentina
25
India
24
South Africa
21
Global
21
Colombia
20
Ecuador
20
Bolivia
18
Kenya
15
Liberia
14
Peru
14
Chile
14
Western and Central Europe
14
Venezuela
14
Ethiopia
13
Brazil
13
El Salvador
13
Germany
11
Nigeria
10
Philippines
8
Zambia
8
Tanzania
8
Mozambique
8
Spain
8
Indonesia
7
Africa
7
Eastern Europe
7
Ghana
6
Uganda
6
Nepal
6
Sierra Leone
5
Botswana
4
Zimbabwe
3
Haiti
3
Syria
3
Malawi
3
Namibia
3
South–East Asia Region
3
Guinea-Bissau
2
Dominican Republic
2
Switzerland
2
Angola
2
Guatemala
2
Mexico
2
Western Pacific Region
2
Jamaica
2
Cameroon
1
Jordan
1
Afghanistan
1
Cambodia
1
Thailand
1
Rwanda
1
Eswatini/ Swaziland
1
Cuba
1
Ukraine
1
Honduras
1
Lesotho
1
Nicaragua
1
Myanmar / Burma
1
Yemen
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Asia
1
Fiji
1
Qatar
1
Romania
1
Australia
1
Uruguay
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
381
Clinical Guidelines
80
Women & Child Health
43
Public Health
39
Key Resources
17
Pharmacy & Technologies
12
Capacity Building
7
Annual Report MEDBOX
1
Toolboxes
TB
89
COVID-19
87
AMR
77
Pharmacy
70
Mental Health
64
HIV
44
Disability
19
Planetary Health
19
NCDs
17
Conflict
16
Rapid Response
16
Refugee
16
Caregiver
11
NTDs
9
Global Health Education
8
Natural Hazards
7
Zika
7
Ebola
4
Polio
3
Specific Hazards
3
Cholera
2
Typhoon
2
Health Financing Toolbox
2
Social Ethics
1
Technical Update
HIV Treatment
July 2017
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis...
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
World Health Organization. (2021). Minimum technical standards and recommendations for reproductive, maternal, newborn and child health care for emergency medical teams. World Health Organization.
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee...
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ...
While infections that develop during hospitalization may appear to be an uncommon but recognized risk of hospital care today, the incidence of these infections has been increasing dramatically during the last 2 to 3 decades, and the risk of acquiring an organism that is resistant to 1 or more antibi...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable and sustainable an...
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal and plant sectors, and their release into the environment. The purpose of the document is to identify existing instruments and standards in ...
Asthma is the commonest chronic childhood disease and encompasses a spectrum of airway diseases with similar symptoms. Inaccurate diagnosis remains common, especially in younger children, with failure to characterize the different “asthmas.” Children worldwide repeatedly suffer symptoms which se...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
